Patanol Related Clinical Trials
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Recruiting]
Comparing Patient Satisfaction With Pataday or Bepreve [Recruiting]
Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Not yet recruiting]
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients [Recruiting]
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Recruiting]
Mast-Cell Stabilizing Effects of Olopatadine [Completed]
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis [Completed]
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [Completed]
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis [Recruiting]
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis [Recruiting]
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis [Recruiting]
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients [Recruiting]
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Recruiting]
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Recruiting]
Allergic Eye Disease Tear Mediators [Recruiting]
Comparison of CL Wear Between Two Allergy Drops [Not yet recruiting]
An Open-label, Long-term Study, With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis [Not yet recruiting]
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Not yet recruiting]
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis [Completed]
Safety Study of Olpatadine Nasal Spray [Active, not recruiting]
|
